Wells Fargo’s Taysha Gene Therapies TSHA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$820K	Sell	183,334 -121,752	-40%	-$566K	﹤0.01%	3854
2025 Q4	$1.68M	Buy	305,086 +159,988	+110%	+$777K	﹤0.01%	3588
2025 Q3	$474K	Buy	145,098 +37,864	+35%	+$107K	﹤0.01%	4339
2025 Q2	$248K	Sell	107,234 -1,814	-2%	-$3.94K	﹤0.01%	4644
2025 Q1	$152K	Buy	109,048 +5,664	+5%	+$9.47K	﹤0.01%	4866
2024 Q4	$179K	Buy	103,384 +31,457	+44%	+$65.3K	﹤0.01%	4864
2024 Q3	$145K	Buy	71,927 +2,185	+3%	+$4.79K	﹤0.01%	4791
2024 Q2	$156K	Buy	69,742 +62,334	+841%	+$181K	﹤0.01%	4669
2024 Q1	$21.3K	Sell	7,408 -21	-0.3%	-$44	﹤0.01%	5560
2023 Q4	$13.1K	Buy	7,429 +889	+14%	+$1.77K	﹤0.01%	5756
2023 Q3	$20.7K	Sell	6,540 -12,653	-66%	-$23.6K	﹤0.01%	5583
2023 Q2	$12.7K	Buy	19,193 +15,148	+374%	+$11K	﹤0.01%	5849
2023 Q1	$3.23K	Buy	4,045 +2,777	+219%	+$3.59K	﹤0.01%	6147
2022 Q4	$2.87K	Buy	1,268 +318	+33%	+$644	﹤0.01%	5919
2022 Q3	$2K	Buy	950 +787	+483%	+$2.86K	﹤0.01%	6203
2022 Q2	$1K	Sell	163 -1,282	-89%	-$5.09K	﹤0.01%	6615
2022 Q1	$9K	Sell	1,445 -8,014	-85%	-$59.9K	﹤0.01%	6320
2021 Q4	$110K	Buy	+9,459	New	+$143K	﹤0.01%	5580
2021 Q2	–	Sell	-57,412	Closed	-$1.17M	–	7450
2021 Q1	$1.17M	Buy	57,412 +44,971	+361%	+$1.22M	﹤0.01%	4143
2020 Q4	$330K	Buy	+12,441	New	+$268K	﹤0.01%	4813